CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Privia Health Group Inc   (PRVA)
Other Ticker:  
 
 

PRVA's Net Income Growth by Quarter and Year

Privia Health Group Inc 's Net Income results by quarter and year




PRVA Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 2.32 16.85 -11.89
III Quarter September - 5.94 0.56 -10.89
II Quarter June 4.64 6.36 -11.38 -173.49
I Quarter March 3.06 6.40 -18.09 5.62
FY   7.70 21.02 -12.06 -190.65



PRVA Net Income second quarter 2024 Y/Y Growth Comment
Privia Health Group Inc reported fall in Net Income in the second quarter 2024 by -27% to $ 4.64 millions, from the same quarter in 2023.
The drop in the second quarter 2024 Privia Health Group Inc 's Net Income compares unfavorably to the Company's average Net Income decrease of -2.38%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 3 other companies have achieved higher Net Income growth. While Privia Health Group Inc ' s Net Income drop of -27% ranks overall at the positon no. 92 in the second quarter 2024.


PRVA Net Income ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - -86.23 % - -
III Quarter September - 960.71 % - -
II Quarter June -27 % - - -
I Quarter March -52.19 % - - -
FY   - - - -

Financial Statements
Privia Health Group Inc 's second quarter 2024 Net Income $ 4.64 millions PRVA's Income Statement
Privia Health Group Inc 's second quarter 2023 Net Income $ 6.36 millions Quarterly PRVA's Income Statement
New: More PRVA's historic Net Income Growth >>


PRVA Net Income (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - -60.94 % 2908.93 % -
III Quarter September - -6.6 % - -
II Quarter June 51.73 % -0.63 % - -
I Quarter March 31.9 % -62.02 % - -
FY (Year on Year)   - - - -


Compare PRVA Profitability >> Back to PRVA Growth rate Comparisons >>


Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #4
Healthcare Sector #13
Overall #92

Net Income Y/Y Growth Statistics
High Average Low
42.31 % -2.38 % -47.08 %
(Mar 31 2024)   (Jun 30 2024)
Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #4
Healthcare Sector #13
Overall #92
Net Income Y/Y Growth Statistics
High Average Low
42.31 % -2.38 % -47.08 %
(Mar 31 2024)   (Jun 30 2024)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Privia Health Group Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
2930.22 % 411.93 % -62 %
(Dec 31 2022)  


PRVA's II. Quarter Q/Q Net Income Comment
Privia Health Group Inc achieved in the II. Quarter 2024 below company average Net Income jump of 51.73% quarter on quarter, to $ 4.64 millions.

II. Quarter 2024 performance seem to be paradoxical, even if below the ordinary increase of 411.93 %, yet it shows a quite acceleration relative to the -0.63% in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Net Income quarter on quarter growth. While Privia Health Group Inc 's Net Income growth quarter on quarter, overall rank is 262.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #17
Overall #262
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #17
Overall #262
Net Income Q/Q Growth Statistics
High Average Low
2930.22 % 411.93 % -62 %
(Dec 31 2022)  


PRVA's II. Quarter Q/Q Net Income Comment
Privia Health Group Inc achieved in the II. Quarter 2024 below company average Net Income jump of 51.73% quarter on quarter, to $ 4.64 millions.

Albeit the II. Quarter 2024 results were below the regular of 411.93 %, that has been still encouraging sign, as the II. Quarter expension, eclipses the -0.63% rise in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Net Income quarter on quarter growth. While Privia Health Group Inc 's Net Income growth quarter on quarter, overall rank is 262.


Privia Health Group Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Net Income 12 Months Ending $ 15.97 $ 17.68 $ 21.03 $ 35.55 $ 30.17
Y / Y Net Income Growth (TTM) -47.08 % 42.31 % - - -
Year on Year Net Income Growth Overall Ranking # 253 # 227 # 0 # 0 # 0
Seqeuential Net Income Change (TTM) -9.71 % -15.91 % -40.85 % 17.85 % 142.78 %
Seq. Net Income Growth (TTM) Overall Ranking # 92 # 83 # 122 # 189 # 76

New: More PRVA's historic Net Income Growth >>



Cumulative Net Income growth Comment
For the 12 months ended Jun 30 2024 Privia Health Group Inc reported a sharp drop in Net Income by -47.08% year on year, to $16 millions, compare to the 42.31% growth at Mar 31 2024.

Within the Healthcare sector 25 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 227 to 253.

Net Income TTM Q/Q Growth Statistics
High Average Low
42.31 %
-2.38 %
-47.08 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 4
Healthcare Sector # 26
Overall # 253

Net Income TTM Y/Y Growth Statistics
High Average Low
42.31 %
-2.38 %
-47.08 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 13
S&P 500 # 92
Cumulative Net Income growth Comment
For the 12 months ended Jun 30 2024 Privia Health Group Inc reported a sharp drop in Net Income by -47.08% year on year, to $16 millions, compare to the 42.31% growth at Mar 31 2024.

Within the Healthcare sector 25 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 227 to 253.

Net Income TTM Q/Q Growth Statistics
High Average Low
42.31 %
-2.38 %
-47.08 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 4
Healthcare Sector # 26
Overall # 253

Net Income TTM Y/Y Growth Statistics
High Average Low
42.31 %
-2.38 %
-47.08 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 13
S&P 500 # 92




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PRVA's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PRVA's Competitors
Net Income Growth for Privia Health Group Inc 's Suppliers
Net Income Growth for PRVA's Customers

You may also want to know
PRVA's Annual Growth Rates PRVA's Profitability Ratios PRVA's Asset Turnover Ratio PRVA's Dividend Growth
PRVA's Roe PRVA's Valuation Ratios PRVA's Financial Strength Ratios PRVA's Dividend Payout Ratio
PRVA's Roa PRVA's Inventory Turnover Ratio PRVA's Growth Rates PRVA's Dividend Comparisons



Companies with similar Net Income sharp drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2024
Biogen Inc -1.63%$ -1.635 millions
Embecta Corp -3.29%$ -3.289 millions
Quest Diagnostics Inc-3.61%$ -3.614 millions
Abbott Laboratories-5.31%$ -5.309 millions
Zoetis Inc -6.87%$ -6.866 millions
Idexx Laboratories Inc-9.34%$ -9.337 millions
Prestige Consumer Healthcare Inc -11.89%$ -11.893 millions
Align Technology inc -13.64%$ -13.639 millions
National Research Corporation-15.10%$ -15.097 millions
Dariohealth Corp -17.94%$ -17.938 millions
Bristol myers Squibb Company-18.92%$ -18.922 millions
Organon and Co -19.42%$ -19.421 millions
U S Physical Therapy Inc-21.21%$ -21.206 millions
Pacira Biosciences inc -26.69%$ -26.693 millions
Privia Health Group Inc -27.00%$ -26.997 millions
West Pharmaceutical Services Inc -28.24%$ -28.240 millions
Neurocrine Biosciences Inc -31.94%$ -31.937 millions
Abbvie Inc -32.26%$ -32.264 millions
Lifevantage Corp-33.62%$ -33.622 millions
Lantheus Holdings Inc -34.06%$ -34.057 millions
Viemed Healthcare Inc -36.61%$ -36.609 millions
Vaso Corporation-44.26%$ -44.257 millions
Nature s Sunshine Products inc -44.42%$ -44.415 millions
Royalty Pharma Plc-44.67%$ -44.675 millions
Globus Medical Inc -44.97%$ -44.968 millions
Amgen Inc -45.90%$ -45.903 millions
Surgery Partners Inc -50.78%$ -50.780 millions
Radnet Inc -52.29%$ -52.294 millions
Option Care Health Inc -53.63%$ -53.635 millions
Pro dex Inc -58.30%$ -58.303 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com